| WHAT: |
Members of the media are invited to come see an amazing new
PET/CT at the Hospital of the University of Pennsylvania.
Its powerful advanced "time-of-flight" technology,
pioneered in part at Penn, makes it the first clinical machine
of its kind in the world. With this technology, we can take
a precisely detailed “look” inside the body, gathering
and using this information to create an image.
Using this advanced "time-of-flight" technology
on our uniquely outfitted PET/CT instrument, Penn radiologists
are able to get much better image quality, leading them to
be better able to detect lesions. This technology is used
to retrieve excellent high-resolution functional images of
the body. Ultimately, this technology may lead physicians
to “a clearer view inside a patient” to better
understand what’s wrong and how to treat it. |
| WHEN: |
Wednesday, June 21
11 a.m. - 12 p.m.
Timeline:
11:00 a.m. Welcoming remarks and explanation of the new PET/CT
by Dr. Chaitanya Divgi, new Chief of Nuclear Medicine and
Clinical Molecular Imaging
11:15 a.m. Dr. Laurie Loevner, a head and neck imaging specialist,
explains a real-use application of the PET/CT in relation
to cancer patients
11:30 a.m. Tour of PET/CT suite
11:40 a.m. Q & A with Drs. Divgi and Loevner
12:00 p.m. Event ends |
| WHERE: |
Hospital of the University of Pennsylvania
Donner Auditorium - basement level
(Plus, tour of PET/CT suite on 3rd floor)
3400 Spruce Street
Philadelphia, PA 19104 **Valet parking available at
HUP & garage parking available across the street at Penn
Tower** |
NOTE: This event is NOT open to the general public.
The PET/CT system is the latest and greatest in imaging! It tests
patients at the same time, giving radiologists the ability to overlay
both the diagnostic and the functional images - in order to compare
them. This new "combined PET/CT" is a first at the Hospital
of the University of Pennsylvania and is now being utilized clinically
for patients. It has been used for research here since last November.
This particular unit, the GEMINI TF from Philips Medical Systems,
is a one-of-a-kind PET/CT instrument, utilizing advancements in
"time-of-flight" technology. Joel Karp, PhD,
a radiology physicist whose research team has contributed to the
development of this technology for the PET/CT scanner, explains,
“This GEMINI TF has significantly better timing characteristics
than other commercial instruments. The 'time-of-flight' information
that is recorded during the scan is used in reconstructing a higher
quality image, allowing a clearer look at the glucose metabolism
inside the body. This is currently the only commercial PET system
that can do this. And the combination of the PET and the CT allows
us to fuse the two images, thereby correlating the body’s
function with the body’s anatomy.”
Karp continues, "We can precisely identify the time difference
in detection of the two coincident gamma rays to within a half of
a billionth of a second, giving us better localization of the site
of positron annihilation which allows us to calculate a better reconstructed
image. With this 'time-of-flight' technology, the ability to both
quantify and detect lesions is improved compared to other instruments
without this new technology.”
How It's Already Being Utilized to Benefit Patients
Laurie Loevner, MD, is a neuroradiologist who specializes
in head and neck imaging. She’s already utilizing the PET/CT
to look for "hot spots" in cancer patients. “PET
picks up what other imaging can’t. It’s where structure
and function meet; it allows radiologists to 'bridge that anatomical-functional
gap.' We can use this PET/CT to check for early indications of cancer
or to see if the cancer has spread. We can also look to see if a
particular therapy has been successful in treating the cancer.”
A New Face at Penn: Welcome Dr. Divgi
“This PET/CT is the most advanced in the world! By utilizing
the new 'time-of-flight' technology, it can record an event in time
to the billionth of a second,” explains Chaitanya
Divgi, MD, the new Chief of Nuclear Medicine and Clinical
Molecular Imaging. “It can precisely locate events as they
occur, resulting in unsurpassed technological images. Its potential
is phenomenal. It expands our use of PET.”
Coming from the Memorial Sloan-Kettering Cancer Center in New York,
Divgi joined the Department of Radiology at Penn in May. Divgi,
a native of India, has a clinical research focus on radioimmunotherapy
and targeted therapy. He is the author of more than 80 peer reviewed
journal articles and enjoys an international reputation of excellence
in his field.
“This field lets me combine all of my passions - physics,
chemistry and medicine. It satisfies my scientific curiosity,”
Divgi adds.
###
PENN Medicine is a $2.9 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S.News &
World Report's most recent ranking of top research-oriented medical
schools. Supporting 1,400 fulltime faculty and 700 students, the
School of Medicine is recognized worldwide for its superior education
and training of the next generation of physician-scientists and
leaders of academic medicine.
The University of Pennsylvania Health System includes three
hospitals [Hospital of the University of Pennsylvania, which is
consistently ranked one of the nation's few "Honor Roll"
hospitals by U.S.News & World Report; Pennsylvania Hospital,
the nation's first hospital; and Penn Presbyterian Medical Center];
a faculty practice plan; a primary-care provider network; two multispecialty
satellite facilities; and home care and hospice.
|